414
Participants
Start Date
November 30, 2011
Primary Completion Date
March 31, 2012
Study Completion Date
May 31, 2012
Aclidinium bromide
Dosage form: Dry powder. Route of administration: Oral inhalation by Genuair multidose dry powder inhaler Dose and regimen: 1 puff of 400 micrograms in the morning (09:00 ± 1h) and in the evening (21:00 ± 1h)
Tiotropium
Dosage form: Dry powder hard gelatin capsule. Route of administration: Oral inhalation by HandiHaler single-dose dry powder inhaler Dose and regimen: 1 capsule (18 μg) in the morning (09:00 ± 1h)
Placebo
Dosage form: Dry powder Route of administration: Oral inhalation by Genuair multidose dry powder inhaler. 1 puff of placebo in the morning (09:00 ± 1h) and 1 puff in the evening (21:00 ± 1h) AND Oral inhalation by HandiHaler single-dose dry powder inhaler. 1 puff of placebo in the morning (09:00 ± 1h).
Almirall Investigational Site #11, Szigetszentmiklós
Almirall Investigational Site #2, Komárom
Almirall Investigational Site #3, Mátraháza
Almirall Investigational Site #4, Debrecen
Almirall Investigational Site #1, Szarvas
Almirall Investigational Site #4, Berlin
Almirall Investigational Site #12, Berlin
Almirall Investigational Site #10, Berlin
Almirall Investigational Site #8, Berlin
Almirall Investigational Site #20, Berlin
Almirall Investigational Site #21, Berlin
Almirall Investigational Site #2, Berlin
Almirall Investigational Site #23, Rudersdorf
Almirall Investigational Site #6, Schwerin
Almirall Investigational Site #1, Hamburg
Almirall Investigational Site #18, Hamburg
Almirall Investigational Site #3, Großhansdorf
Almirall Investigational Site #17, Lübeck
Almirall Investigational Site #5, Hanover
Almirall Investigational Site #22, Hanover
Almirall Investigational Site #24, Cologne
Almirall Investigational Site #9, Frankfurt
Almirall Investigational Site #16, Wiesbaden
Almirall Investigational Site #9, Humpolec
Almirall Investigational Site #1, Jaroměř
Almirall Investigational Site #3, Mělník
Almirall Investigational Site #13, Dresden
Almirall Investigational Site #14, Jena
Almirall Investigational Site #18, Bialystok
Almirall Investigational Site #8, Bialystok
Almirall Investigational Site #2, Elblag
Almirall Investigational Site #17, Krakow
Almirall Investigational Site #10, Krakow
Almirall Investigational Site #16, Lodz
Almirall Investigational Site #20, Lodz
Almirall Investigational Site #4, Proszowice
Almirall Investigational Site #6, Sopot
Almirall Investigational Site #14, Tarnów
Almirall Investigational Site #19, Warsaw
Almirall Investigational Site #12, Wilkowice-Bystra
Almirall Investigational Site #13, Wroclaw
Lead Sponsor
AstraZeneca
INDUSTRY